Artiva Biotherapeutics, Inc. (ARTV)
6.65
-0.18
(-2.64%)
USD |
NASDAQ |
Oct 05, 10:48
Artiva Biotherapeutics EPS Diluted (Quarterly) : -0.6344 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6344 |
| March 31, 2026 | -0.9529 |
| December 31, 2025 | -0.8453 |
| September 30, 2025 | -0.8794 |
| June 30, 2025 | -0.8718 |
| March 31, 2025 | -0.8344 |
| December 31, 2024 | -0.6626 |
| September 30, 2024 | -0.7194 |
| June 30, 2024 | -0.7664 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.7941 |
| December 31, 2023 | -0.494 |
| September 30, 2023 | 0.4644 |
| March 31, 2023 | -0.9507 |
| March 31, 2022 | -0.6895 |
| December 31, 2021 | -0.6479 |
| March 31, 2021 | -2.430 |
| December 31, 2020 | -0.3373 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Climb Bio, Inc. | -0.1772 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.00M |
| Total Expenses (Quarterly) | 25.00M |
| Enterprise Value | -6.294M |
| Earnings Yield | -49.80% |
| Normalized Earnings Yield | -49.80 |